TropoKine
Based on precision medicine where individuals own biological information is used to ensure receptivity thus, clinical response.
An important anti-inflammatory physiological system, significantly boosted by hyper-concentration and cellular stimulation of IL-1Ra, starting from the patient’s own blood.
IL-1, a proinflammatory cytokine that plays an important role in inflammation adverse effects.
Inflammation occurs after disruption of tissue homeostasis by cell stress, injury or infection. Interleukin 1, as a potent inflammatory cytokine, activates the inflammatory process, and its deregulated signaling causes devastating diseases manifested by severe acute or chronic inflammation and subsequent pain.
Tropokine acts downregulating Interleukin-1 activity by blocking its receptor.
- Safe and feasible treatment modality.
- No red blood cells contamination.
- Eliminate pro-inflammatory white blood cells.
- Concentrated IL-1Ra.
- Autologous interleukin receptor antagonist therapy.
- No risk of immunological response.
- Non-surgical, minimal invasive, no pharmacologic treatment.
- Osteoarthritis of the knee, hip, shoulder, elbow, ankle, first carpometacarpal, acromioclavicular, metacarpophalangeal joints.
- Painful lumbar, thoracic and cervical spinal syndromes: Disc prolapse, compression cervical radiculopathy, lumbar disc protrusion, prolapse and stenosis, spinal osteoarthritis.
- Post-operative and post-fracture conditions – knee and shoulder arthroscopy, cruciate ligament or meniscus surgery.
- Muscle ruptures, tendonitis, including Achilles’ tendon, post-operative conditions after Achilles tendon surgery.
